Non-alcoholic steatohepatitis and hepatic steatosis in patients with adult onset growth hormone deficiency

被引：93
|
作者：
Ichikawa, T
Hamasaki, K
Ishikawa, H
Ejima, E
Eguchi, K
Nakao, K
机构：
[1] Nagasaki Univ, Dept Internal Med 1, Sch Med, Nagasaki 8528501, Japan
[2] Nagasaki Univ, Hlth Res Ctr, Nagasaki 852, Japan
来源：
GUT | 2003年 / 52卷 / 06期
关键词：
D O I：
10.1136/gut.52.6.914
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：914 / 914
页数：1
相关论文
共 50 条
  • [1] Unrecognized hepatic steatosis and non-alcoholic steatohepatitis in adjuvant tamoxifen for breast cancer patients
    Murata, Y
    Ogawa, Y
    Saibara, T
    Nishioka, A
    Fujiwara, Y
    Fukumoto, M
    Inomata, T
    Enzan, H
    Onishi, S
    Yoshida, S
    ONCOLOGY REPORTS, 2000, 7 (06) : 1299 - 1304
  • [2] Beneficial effects of pentoxifylline on hepatic steatosis, fibrosis and necroinflammation in patients with non-alcoholic steatohepatitis
    Satapathy, Sanjaya K.
    Sakhuja, Puja
    Malhotra, Veena
    Sharma, Barjesh C.
    Sarin, Shiv K.
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2007, 22 (05) : 634 - 638
  • [3] Pitavastatin inhibits hepatic steatosis and fibrosis in non-alcoholic steatohepatitis model rats
    Miyaki, Tomokatsu
    Nojiri, Shunsuke
    Shinkai, Noboru
    Kusakabe, Atsunori
    Matsuura, Kentaro
    Iio, Etsuko
    Takahashi, Satoru
    Yan, Ge
    Ikeda, Kazuo
    Joh, Takashi
    HEPATOLOGY RESEARCH, 2011, 41 (04) : 375 - 385
  • [4] Linagliptin alleviates hepatic steatosis and inflammation in a mouse model of non-alcoholic steatohepatitis
    Thomas Klein
    Masato Fujii
    Jan Sandel
    Yuichiro Shibazaki
    Kyoko Wakamatsu
    Michael Mark
    Hiroyuki Yoneyama
    Medical Molecular Morphology, 2014, 47 : 137 - 149
  • [5] CCN1 promotes hepatic steatosis and inflammation in non-alcoholic steatohepatitis
    Linling Ju
    Yan Sun
    Hong Xue
    Lin Chen
    Chunyan Gu
    Jianguo Shao
    Rujian Lu
    Xi Luo
    Jue Wei
    Xiong Ma
    Zhaolian Bian
    Scientific Reports, 10
  • [6] CCN1 promotes hepatic steatosis and inflammation in non-alcoholic steatohepatitis
    Ju, Linling
    Sun, Yan
    Xue, Hong
    Chen, Lin
    Gu, Chunyan
    Shao, Jianguo
    Lu, Rujian
    Luo, Xi
    Wei, Jue
    Ma, Xiong
    Bian, Zhaolian
    SCIENTIFIC REPORTS, 2020, 10 (01) : 3201
  • [7] Linagliptin alleviates hepatic steatosis and inflammation in a mouse model of non-alcoholic steatohepatitis
    Klein, Thomas
    Fujii, Masato
    Sandel, Jan
    Shibazaki, Yuichiro
    Wakamatsu, Kyoko
    Mark, Michael
    Yoneyama, Hiroyuki
    MEDICAL MOLECULAR MORPHOLOGY, 2014, 47 (03) : 137 - 149
  • [8] THYROID HORMONE DECREASES HEPATIC STEATOSIS, INFLAMMATION, AND FIBROSIS IN A DIETARY MOUSE MODEL OF NON-ALCOHOLIC STEATOHEPATITIS (NASH)
    Zhou, Jin
    HEPATOLOGY, 2020, 72 : 1040 - 1040
  • [9] Adult onset type II citrullinemia as a cause of non-alcoholic steatohepatitis
    Takagi, H
    Hagiwara, S
    Hashizume, H
    Kanda, D
    Sato, K
    Sohara, N
    Kakizaki, S
    Takahashi, H
    Mori, M
    Kaneko, H
    Ohwada, S
    Ushikai, M
    Kobayashi, K
    Saheki, T
    JOURNAL OF HEPATOLOGY, 2006, 44 (01) : 236 - 239
  • [10] Role of metabolic lipases and lipotoxicity in the development of non-alcoholic steatosis and non-alcoholic steatohepatitis
    Berlanga, Alba
    Guiu-Jurado, Esther
    Antonio Porras, Jose
    Aragones, Gemma
    Auguet, Teresa
    CLINICA E INVESTIGACION EN ARTERIOSCLEROSIS, 2016, 28 (01): : 47 - 61
12345